Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Secondary Acute Myelogenous Leukemia Evolving From Myeloproliferative Disorder × ruxolitinib × 90 days × Clear all

Sponsor

Conditions

Primary Myelofibrosis 8 Thrombocythemia, Essential 5 Leukemia, Myeloid, Acute 5 Leukemia 5 Recurrence 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Myeloproliferative Disorders 4 Graft vs Host Disease 4 Polycythemia Vera 3 Myelodysplastic-Myeloproliferative Diseases 2 Myelodysplastic Syndromes 2 Lymphoma 2 Leukemia, Prolymphocytic, T-Cell 2 Leukemia, Myelomonocytic, Chronic 2 Glioblastoma 2 Carcinoma, Non-Small-Cell Lung 2 Triple Negative Breast Neoplasms 1 Thalassemia 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, T-Cell 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Monocytic, Acute 1 Leukemia, Large Granular Lymphocytic 1 Inflammatory Breast Neoplasms 1 Hodgkin Disease 1 Hematopoietic and Lymphatic System Neoplasm 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡